Page last updated: 2024-10-30

lomustine and Nausea

lomustine has been researched along with Nausea in 15 studies

Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.

Research Excerpts

ExcerptRelevanceReference
"Thirty-seven consecutive patients with disseminated malignant melanoma and previously untreated with chemotherapy were randomly allocated to receive vindesine, cis-platinum, and etoposide (Regimen A) or vindesine, cis-platinum, and lomustine (Regimen B)."9.05Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine. ( Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S, 1985)
"One hundred and six patients with advanced adenocarcinoma and large cell carcinoma of the lung with no prior chemotherapy were entered in a prospectively randomized trial comparing cyclophosphamide, doxorubicin, and cisplatin versus methotrexate, doxorubicin, cyclophosphamide, and lomustine."5.05Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study. ( Cullinan, S; Eagan, RT; Elliott, T; Etzell, P; Fleming, TR; Krook, JE; Pfeifle, D, 1984)
"Thirty-seven consecutive patients with disseminated malignant melanoma and previously untreated with chemotherapy were randomly allocated to receive vindesine, cis-platinum, and etoposide (Regimen A) or vindesine, cis-platinum, and lomustine (Regimen B)."5.05Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine. ( Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S, 1985)
"Forty-three patients with inoperable or recurring malignant gliomas, and 30 patients with multiple recurring brain metastases were treated with a combination of Adriamycin (45 mg/m2) and 4-dimethyl-epipodophyllotoxin D-thenylidene (VM 26) (60 mg/m2 for 2 days) with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (60 mg/m2 for 2 days)."3.65Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail. ( Gauthier, H; Huguenin, P; Lheritier, J; Mathe, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, TH, 1976)
"Lomustine is a commercially available chloroethyl nitrosourea compound whose antitumor activity in vitro and in animal tumor models exceeds its activity in humans."2.67A phase I trial of weekly lomustine in patients with advanced cancer. ( Benjamin, RS; Gorski, CC; Koller, CA; Legha, SS; Papadopoulos, NE; Plager, C, 1994)
"Thirty-five patients with advanced breast cancer refractory to initial chemotherapy were randomized to receive two-drug doxorubicin-CCNU or three-drug doxorubicin-CCNU-vincristine (VCR) treatment."2.65Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trial. ( Bateman, JR; Block, JB; Chlebowski, RT; Pugh, R; Weiner, JM, 1983)
" The dosage of CCNU was 100 mg/m2 p."2.65The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study. ( Brunner, K; Cuttner, J; Falkson, G; Hansen, HH; Holland, JF; Nissen, NI; Pajak, TF; Selawry, OS; Spurr, CL, 1981)
"It is an effective drug in the treatment of malignant melanoma with better response rates in women than in men."2.64Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group. ( Hill, G; Johnson, RO; Krementz, E; Metter, G; Wilson, W, 1976)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-199014 (93.33)18.7374
1990's1 (6.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diggs, CH1
Wiernik, PH1
Sutherland, JC1
Krook, JE1
Fleming, TR1
Eagan, RT1
Cullinan, S1
Pfeifle, D1
Elliott, T1
Etzell, P1
Chlebowski, RT2
Pugh, R1
Weiner, JM1
Block, JB2
Bateman, JR2
Whitehead, RP1
Rosenbaum, PR1
Carbone, PP1
Hansen, HH1
Selawry, OS1
Pajak, TF2
Spurr, CL1
Falkson, G1
Brunner, K1
Cuttner, J1
Nissen, NI1
Holland, JF1
Gagliano, RG1
Panettiere, FJ1
Haas, CD1
Baker, L1
Hewlett, J1
Stuckey, WJ1
O'Bryan, RM1
Bottomley, R1
Heilburn, LK1
Koller, CA1
Gorski, CC1
Benjamin, RS1
Legha, SS1
Papadopoulos, NE1
Plager, C1
Reagan, TJ1
Bisel, HF1
Childs, DS1
Layton, DD1
Rhoton, AL1
Taylor, WF1
Stolinsky, DC1
Bull, FE1
Johnson, RO1
Metter, G1
Wilson, W1
Hill, G1
Krementz, E1
Wasserman, TH1
Pouillart, P1
Mathe, G1
Thy, TH1
Lheritier, J1
Poisson, M1
Huguenin, P1
Gauthier, H1
Morin, P1
Parrot, R1
Page, JP1
Levi, JA1
Woods, RL1
Tattersall, MN1
Fox, RM1
Coates, AS1
Bajetta, E1
Buzzoni, R1
Viviani, S1
Vaglini, M1
Nava, M1
Bonadonna, G1
Chlebowski, JS1
Herrold, J1
Richardson, B1
Ali, I1
Oktay, E1

Trials

10 trials available for lomustine and Nausea

ArticleYear
Treatment of advanced untreated Hodgkin's disease with SCAB--an alternative to MOPP.
    Cancer, 1981, Jan-15, Volume: 47, Issue:2

    Topics: Adult; Bleomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodg

1981
Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Cancer treatment reports, 1984, Volume: 68, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell;

1984
Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trial.
    Cancer, 1983, Aug-15, Volume: 52, Issue:4

    Topics: Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans;

1983
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
    Cancer, 1981, Jan-01, Volume: 47, Issue:1

    Topics: Adult; Carmustine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration S

1981
A phase I trial of weekly lomustine in patients with advanced cancer.
    Cancer, 1994, Jan-01, Volume: 73, Issue:1

    Topics: Administration, Oral; Adult; Aged; Capsules; Carcinoma, Renal Cell; Drug Administration Schedule; Dr

1994
Controlled study of CCNU and radiation therapy in malignant astrocytoma.
    Journal of neurosurgery, 1976, Volume: 44, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Digestive System; Drug Evaluation; Glioblastoma; Hematopoiesis; Humans

1976
Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
    Cancer treatment reports, 1976, Volume: 60, Issue:2

    Topics: Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Femal

1976
Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma.
    Cancer treatment reports, 1985, Volume: 69, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Do

1985
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
    American journal of clinical oncology, 1985, Volume: 8, Issue:5

    Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic

1985
Doxorubicin, cyclophosphamide, CCNU, and vincristine with or without cisplatinum in non-small cell lung cancer.
    American journal of clinical oncology, 1985, Volume: 8, Issue:2

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma; Cisplati

1985

Other Studies

5 other studies available for lomustine and Nausea

ArticleYear
Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
    Cancer treatment reports, 1984, Volume: 68, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cisplatin; Cyclophosp

1984
Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. A Southwest Oncology Group study.
    Cancer clinical trials, 1981,Winter, Volume: 4, Issue:4

    Topics: Adenocarcinoma; Colonic Neoplasms; Deoxyguanosine; Drug Evaluation; Drug Therapy, Combination; Human

1981
Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Oncology, 1975, Volume: 31, Issue:5-6

    Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Carcinoma, Bronchogenic; Carcinoma, Small Cell;

1975
The nitrosoureas: an outline of clinical schedules and toxic effects.
    Cancer treatment reports, 1976, Volume: 60, Issue:6

    Topics: Administration, Oral; Bone Marrow; Capsules; Carmustine; Humans; Injections, Intravenous; Lomustine;

1976
Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
    Cancer, 1976, Volume: 38, Issue:5

    Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Glioma

1976